Nateglinide
- Product NDC
- 0591-3355
- 11-digit product format
- 005913355
- Labeler code
- 0591
- Product ID
- 0591-3355_ead87332-2796-4cae-b377-5e54aae8a3ae
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Nateglinide
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Actavis Pharma, Inc.
- Application
- ANDA077462
- Marketing category
- ANDA
- Marketing start
- 2011-05-18
- Marketing end
- 0000-00-00
- Substance
- NATEGLINIDE
- Active strength
- 120 mg/1
- Pharmacologic classes
- Glinide [EPC],Potassium Channel Antagonists [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2020-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| NATEGLINIDE | ACTIVE INGREDIENT | 41X3PWK4O2 | NATEGLINIDE TABLET [WATSON LABORATORIES, INC.] | 7 | |
| NATEGLINIDE | ACTIVE MOIETY | 41X3PWK4O2 | NATEGLINIDE TABLET [WATSON LABORATORIES, INC.] | 7 | |
| ALUMINUM OXIDE | INACTIVE INGREDIENT | LMI26O6933 | NATEGLINIDE TABLET [WATSON LABORATORIES, INC.] | 7 | |
| COLLOIDAL SILICON DIOXIDE | INACTIVE INGREDIENT | ETJ7Z6XBU4 | NATEGLINIDE TABLET [WATSON LABORATORIES, INC.] | 7 | |
| FD&C RED NO. 40 | INACTIVE INGREDIENT | WZB9127XOA | NATEGLINIDE TABLET [WATSON LABORATORIES, INC.] | 7 | |
| FERRIC OXIDE BLACK | INACTIVE INGREDIENT | XM0M87F357 | NATEGLINIDE TABLET [WATSON LABORATORIES, INC.] | 7 | |
| FERRIC OXIDE RED | INACTIVE INGREDIENT | 1K09F3G675 | NATEGLINIDE TABLET [WATSON LABORATORIES, INC.] | 7 | |
| FUMARIC ACID | INACTIVE INGREDIENT | 88XHZ13131 | NATEGLINIDE TABLET [WATSON LABORATORIES, INC.] | 7 | |
| HYPROMELLOSE 2910 (3 MPA.S) | INACTIVE INGREDIENT | 0VUT3PMY82 | NATEGLINIDE TABLET [WATSON LABORATORIES, INC.] | 7 | |
| HYPROMELLOSE 2910 (6 MPA.S) | INACTIVE INGREDIENT | 0WZ8WG20P6 | NATEGLINIDE TABLET [WATSON LABORATORIES, INC.] | 7 | |
| LACTOSE MONOHYDRATE | INACTIVE INGREDIENT | EWQ57Q8I5X | NATEGLINIDE TABLET [WATSON LABORATORIES, INC.] | 7 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | NATEGLINIDE TABLET [WATSON LABORATORIES, INC.] | 7 | |
| POLYSORBATE 80 | INACTIVE INGREDIENT | 6OZP39ZG8H | NATEGLINIDE TABLET [WATSON LABORATORIES, INC.] | 7 | |
| SODIUM STARCH GLYCOLATE TYPE A POTATO | INACTIVE INGREDIENT | 5856J3G2A2 | NATEGLINIDE TABLET [WATSON LABORATORIES, INC.] | 7 | |
| STARCH, CORN | INACTIVE INGREDIENT | O8232NY3SJ | NATEGLINIDE TABLET [WATSON LABORATORIES, INC.] | 7 | |
| TITANIUM DIOXIDE | INACTIVE INGREDIENT | 15FIX9V2JP | NATEGLINIDE TABLET [WATSON LABORATORIES, INC.] | 7 | |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 0591-3355 | NATEGLINIDE TABLET [ACTAVIS PHARMA, INC.] | 11 | Legacy NDC | 20230805_a7e9f62e-32f8-4a89-8588-74d029c8f6a2.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 0591-3355-01 | 00591335501 | 100 TABLET in 1 BOTTLE, PLASTIC (0591-3355-01) | 100 tablet | 2011-05-18 | 0000-00-00 | No | No | Current |